Fact CheckerSign in

NCT04273022Completed

Effect of Exercise on Biomarkers in SCT

The Effect of Exercise on Resting Biomarkers in Subjects With Sickle Cell Trait

Source: ClinicalTrials.gov · Last updated 28 Jan 2025

Brief summary (registry, in English)

This study measures the effect of exercise on a variety of biomarkers in blood and urine selected to evaluate the physiological pathways of hemolysis, myolysis, thrombosis, inflammation, and renal function in subjects with sickle cell trait. These pathways have been shown to be associated with adverse events in athletes and warfighters with SCT upon protracted, repeated, strenuous exertion. Changes in biomarkers post-exercise compared to pre-exercise (and compared to healthy controls) suggest activation of the associated pathway(s) which may contribute to exercise-related events in athletes and warfighters and subclinical complications in non-athletes.

Status (registry)
Completed
Study type
Interventional
Enrollment
12 (actual)
First submitted
11 Feb 2020
Start date
27 Dec 2021
Primary completion date
31 Dec 2024
Lead sponsor
St. Louis University
NCT number
NCT04273022

What you commit to

  • Study type: Interventional
  • Participants enrolled: 12
  • From 27 Dec 2021 to the primary completion date, 31 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • have other self-reported conditions known to cause blood coagulation activation, myocyte destruction, hemolysis, chronic inflammation, or renal disease
  • any condition that places subjects at risk during exercise.

Other

  • Subjects will be excluded if they:
  • weigh less than 110 pounds,
  • are pregnant,
  • have hemoglobinopathies (other than sickle cell trait) as determined by Hb electrophoresis,

Who the study is looking for

  • Health subjects with sickle cell trait (AS)
  • Ages 18-70 years
  • Healthy subjects without sickle cell trait (AA)
  • Ages 18-70 years

Age in the registry: 18 years to 70 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Saint Louis University
Coordinator of this site? Confirm its status
St LouisUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.